Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

dc.contributor.authorBuyukkaya, Eyup
dc.contributor.authorPoyraz, Fatih
dc.contributor.authorKarakas, Mehmet F.
dc.contributor.authorKurt, Mustafa
dc.contributor.authorAkcay, Adnan B.
dc.contributor.authorAkpinar, Ibrahim
dc.contributor.authorMotor, Sedat
dc.date.accessioned2024-09-18T21:03:01Z
dc.date.available2024-09-18T21:03:01Z
dc.date.issued2013
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractAlthough monocyte chemoattractant protein-1 (MCP-1) levels are increased in patients with ST-segment elevation myocardial infarction, the prognostic value of MCP-1 in primary percutaneous coronary intervention (pPCI) is not clear. The goal of the present study was to investigate the association of MCP-1 levels with myocardial perfusion and prognosis in patients with ST-segment elevation myocardial infarction undergoing pPCI. Consecutive pPCI patients (n = 192) were assigned to tertiles according to their admission serum MCP-1 levels. Angiographic no-reflow, Thrombolysis In Myocardial Infarction flow grade, myocardial blush grade, and ST-segment resolution were assessed. Mortality and major adverse cardiac events were evaluated during hospitalization and at the 3-year clinical follow-up visit. Failure of ST resolution was associated with greater admission MCP-1 levels. The risk of no-reflow (Thrombolysis In Myocardial Infarction flow <= 2 or Thrombolysis In Myocardial Infarction flow 3 with final myocardial blush grade <= 2 after pPCI and ST resolution <30%) increased as the admission MCP-1 increased. The 3-year mortality increased as the MCP-1 level increased (8% vs 22% vs 28% for the 3 tertiles, p <0.01). Multivariate logistic regression analysis demonstrated that MCP-1 levels at admission are a significant independent correlate of 3-year mortality in patients with no-reflow as detected by myocardial blush grade. A receiver operating characteristics analysis identified an optimum cut point of >= 254 pg/ml, which was associated with a negative predictive value of 95% in association with 1-year mortality. In conclusion, the plasma MCP-1 levels at admission are independently associated with the development of no-reflow and 3-year mortality in patients with ST-segment elevation myocardial infarction undergoing pPCI. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.en_US
dc.identifier.doi10.1016/j.amjcard.2013.03.011
dc.identifier.endpage193en_US
dc.identifier.issn0002-9149
dc.identifier.issn1879-1913
dc.identifier.issue2en_US
dc.identifier.pmid23601576en_US
dc.identifier.scopus2-s2.0-84879839616en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage187en_US
dc.identifier.urihttps://doi.org/10.1016/j.amjcard.2013.03.011
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13207
dc.identifier.volume112en_US
dc.identifier.wosWOS:000322206500008en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherExcerpta Medica Inc-Elsevier Science Incen_US
dc.relation.ispartofAmerican Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAngiographic Impaired Reperfusionen_US
dc.subjectTerm Clinical-Outcomesen_US
dc.subjectPlasma-Levelsen_US
dc.subjectPoor-Prognosisen_US
dc.subjectAngioplastyen_US
dc.subjectAssociationen_US
dc.subjectActivationen_US
dc.subjectMarkersen_US
dc.subjectTrialsen_US
dc.subjectLevelen_US
dc.titleUsefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Interventionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full Text
Boyut:
517.32 KB
Biçim:
Adobe Portable Document Format